Chronic myelomonocytic leukemia patients with RAS pathway mutations show high in vitro myeloid colony formation in the absence of exogenous growth factors-Reference-Cited by-同舟云学术

Chronic myelomonocytic leukemia patients with RAS pathway mutations show high in vitro myeloid colony formation in the absence of exogenous growth factors

Published:2016-08-18 Issue:11 Volume:30 Page:2280-2281
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Geissler K,Jäger E,Barna A,Alendar T,Ljubuncic E,Sliwa T,Valent P

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2016235.pdf

Reference8 articles.

1. Akutagawa J, Huang TQ, Epstein I, Chang T, Quirindongo-Crespo M, Cottonham CL et al. Targeting the PI3K/Akt pathway in murine MDS/MPN driven by hyperactive RAS. Leukemia 2016; 30: 1335–1343.

2. Itzykson R, Kosmider O, Renneville A, Morabito M, Preudhomme C, Berthon C et al. Clonal architecture of chronic myelomonocytic leukemias. Blood 2013; 121: 2186–2198.

3. Niemeyer CM . RAS diseases in children. Haematologica 2014; 99: 1653–1662.

4. Geissler K, Hinterberger W, Bettelheim P, Haas O, Lechner K . Colony growth characteristics in chronic myelomonocytic leukemia. Leuk Res 1988; 12: 373–377.

5. Geissler K, Ohler L, Födinger M, Virgolini I, Leimer M, Kabrna E et al. Interleukin 10 inhibits growth and granulocyte/macrophage colony-stimulating factor production in chronic myelomonocytic leukemia cells. J Exp Med 1996; 184: 1377–1384.

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting which subsets of patients with myelodysplastic neoplasms are more likely to progress to overt chronic myelomonocytic leukemia;Leukemia & Lymphoma;2024-07-14

2. NLRP3 inflammasome activation and symptom burden in KRAS-mutated CMML patients is reverted by IL-1 blocking therapy;Cell Reports Medicine;2023-12

3. <i>TET2</i> mutational status affects myelodysplastic syndrome evolution to chronic myelomonocytic leukemia;Haematologica;2023-04-27

4. Multistep pathogenesis of chronic myelomonocytic leukemia in patients;European Journal of Haematology;2022-03-23

5. Molecular Pathogenesis of Chronic Myelomonocytic Leukemia and Potential Molecular Targets for Treatment Approaches;Frontiers in Oncology;2021-09-30